JWM
BIIB icon

Janiczek Wealth Management’s Biogen BIIB Stock Holding History

Janiczek Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$28.3K Sell
122
-197
-62% -$42.8K 0.01% 499
2024
Q1 		$68.8K Sell
319
-63
-16% -$14.8K 0.01% 361
2023
Q4 		$98.9K Buy
382
+12
+3% +$2.95K 0.02% 267
2023
Q3 		$95.1K Buy
370
+6
+2% +$1.6K 0.03% 256
2023
Q2 		$104K Buy
364
+21
+6% +$6.25K 0.03% 212
2023
Q1 		$98.8K Sell
343
-115
-25% -$31.8K 0.03% 215
2022
Q4 		$132K Buy
458
+17
+4% +$4.8K 0.04% 183
2022
Q3 		$112K Sell
441
-134
-23% -$28.5K 0.04% 179
2022
Q2 		$124K Buy
575
+31
+6% +$6.34K 0.04% 174
2022
Q1 		$115K Buy
544
+405
+291% +$88.1K 0.03% 186
2021
Q4 		$33K Sell
139
-322
-70% -$82.8K 0.01% 385
2021
Q3 		$130K Buy
461
+154
+50% +$50.5K 0.05% 137
2021
Q2 		$106K Buy
307
+27
+10% +$8.18K 0.04% 147
2021
Q1 		$78K Buy
280
+255
+1,020% +$68.8K 0.03% 175
2020
Q4 		$6K Sell
25
-9
-26% -$2.32K ﹤0.01% 545
2020
Q3 		$10K Buy
+34
New +$9.48K 0.01% 231
2019
Q3 		– Sell
-150
Closed -$35K – 165
2019
Q2 		$35K Buy
+150
New +$34.6K 0.02% 77

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janiczek Wealth Management's BIIB Position: Q2 2024 in Review

Janiczek Wealth Management reduced its Biogen (BIIB) stake by 62% in Q2 2024, selling an estimated $42.8K and leaving 122 shares worth $28.3K. The position accounts for 0.01% of the portfolio, ranked #499.

Janiczek Wealth Management first reported a position in BIIB in Q2 2019 and has held it in 17 quarters since. The position peaked at $132K in Q4 2022. 943 funds tracked by Wall St. Rank hold BIIB as of Q2 2024.

  • Janiczek Wealth Management held 122 shares of Biogen worth $28.3K as of Q2 2024.
  • Janiczek Wealth Management sold 197 Biogen shares in Q2 2024, an estimated $42.8K.
  • Biogen made up 0.01% of Janiczek Wealth Management's portfolio in Q2 2024, its #499 holding.
  • Janiczek Wealth Management first reported a position in Biogen in Q2 2019 and has held it in 17 quarters since.
  • Janiczek Wealth Management's Biogen position peaked at $132K in Q4 2022.
  • 943 funds tracked by Wall St. Rank held Biogen as of Q2 2024.

Based on Janiczek Wealth Management's 13F filing for Q2 2024, filed 25 Jul 2024.